KUALA LUMPUR: RHB Research reiterated its "buy" recommendation on KPower Bhd following its acquisition of a 70% stake in Granulab to venture into the medical sector.
"We have been guided that Granulab has been incurring minimal losses of >MYR1m in the past, but management is confident that such an acquisition will enable KPower to execute larger business expansion activities," it said in a note.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
